Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics

Journal of Lipid Research

Volumn 48, Issue 5, 2007, Pages 1204-1211

  Magkos, Faidon ^a,b   Patterson, Bruce W ^a   Mittendorfer, Bettina ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Hepatic lipid metabolism; Lipoprotein kinetics; Reliability; Repeatability; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN B100; FATTY ACID; TRACER; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; ISOTOPE TRACING; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; MEAN RESIDENCE TIME; NORMAL HUMAN; OUTCOME VARIABLE; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN SECRETION; REPRODUCIBILITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEIN B-100; HUMANS; ISOTOPES; KINETICS; LIPOPROTEINS, VLDL; MALE; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES;

EID: 34248141585     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D600048-JLR200     Document Type: Article

References (49)

1. Castelli, W. P. 1992. Epidemiology of triglycerides: a view from Framingham. Am. J. Cardiol. 70: 3H-9H.
2. Hokanson, J. E., and M. A. Austin. 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3: 213-219.
3. Barrett, P. H., D. C. Chan, and G. F. Watts. 2006. Design and analysis of lipoprotein tracer kinetics studies in humans. J. Lipid Res. 47: 1607-1619.
4. Adiels, M., C. Packard, M. J. Caslake, P. Stewart, A. Soro, J. Westerbacka, B. Wennberg, S. O. Olofsson, M. R. Taskinen, and J. Boren. 2005. A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions. J. Lipid Res. 46: 58-67.
5. Magkos, F., and L. S. Sidossis. 2004. Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the variousmethods really are. Curr. Opin. Clin. Nutr. Metab. Care. 7: 547-555.
6. Sidossis, L. S., F. Magkos, B. Mittendorfer, and R. R. Wolfe. 2004. Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man. Clin. Nutr. 23: 457-466.
7. Patterson, B. W., B. Mittendorfer, N. Elias, R. Satyanarayana, and S. Klein. 2002. Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J. Lipid Res. 43: 223-233.
8. Burnett, J. R., and P. H. Barrett. 2002. Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies. Crit. Rev. Clin. Lab. Sci. 39: 89-137.
9. Klein, S., B. Mittendorfer, J. C. Eagon, B. Patterson, L. Grant, N. Feirt, E. Seki, D. Brenner, K. Korenblat, and J. McCrea. 2006. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 130: 1564-1572.
10. Magkos, F., D. C. Wright, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer. 2006. Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men. Am. J. Physiol. Endocrinol. Metab. 290: E355-E362.
11. Magkos, F., B. W. Patterson, and B. Mittendorfer. 2006. No effect of menstrual cycle phase on basal very low density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am. J. Physiol. Endocrinol. Metab. 291: E1243-E1249.
12. Malmstrom, R., C. J. Packard, M. Caslake, D. Bedford, P. Stewart, H. Yki-Jarvinen, J. Shepherd, and M. R. Taskinen. 1997. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 40: 454-462.
13. Mittendorfer, B., B. W. Patterson, and S. Klein. 2003. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Am. J. Physiol. Endocrinol. Metab. 284: E549-E556.
14. Reeds, D. N., B. Mittendorfer, B. W. Patterson, W. G. Powderly, K. E. Yarasheski, and S. Klein. 2003. Alterations in lipid kinetics in men with HIV-dyslipidemia. Am. J. Physiol. Endocrinol. Metab. 285: E490-E497.
15. Mittendorfer, B., and L. S. Sidossis. 2001. Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets. Am. J. Clin. Nutr. 73: 892-899.
16. Parks, E. J., R. M. Krauss, M. P. Christiansen, R. A. Neese, and M. K. Hellerstein. 1999. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J. Clin. Invest. 104: 1087-1096.
17. Lewis, G. F., K. D. Uffelman, L. W. Szeto, and G. Steiner. 1993. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 42: 833-842.
18. Lewis, G. F., B. Zinman, K. D. Uffelman, L. Szeto, B. Weller, and G. Steiner. 1994. VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin. Am. J. Physiol. 267: E566-E572.
19. Lewis, G. F., K. D. Uffelman, L. W. Szeto, B. Weller, and G. Steiner. 1995. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest. 95: 158-166.
20. Barrows, B. R., and E. J. Parks. 2006. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 91: 1446-1452.
21. Astles, J. R., F. A. Sedor, and J. G. Toffaletti. 1996. Evaluation of the YSI 2300 glucose analyzer: algorithm-corrected results are accurate and specific. Clin. Biochem. 29: 27-31.
22. Chua, K. S., and I. K. Tan. 1978. Plasma glucose measurement with the Yellow Springs Glucose Analyzer. Clin. Chem. 24: 150-152.
23. Hales, C. N., and P. J. Randle. 1963. Immunoassay of insulin with insulin-antibody precipitate. Biochem. J. 88: 137-146.
24. Morgan, C. R., and A. Lazarow. 1962. Immunoassay of insulin using a two-antibody system. Proc. Soc. Exp. Biol. Med. 110: 29-32.
25. Patterson, B. W., G. Zhao, N. Elias, D. L. Hachey, and S. Klein. 1999. Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J. Lipid Res. 40: 2118-2124.
26. McGowan, M. W., J. D. Artiss, D. R. Strandbergh, and B. Zak. 1983. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29: 538-542.
27. Rifai, N., and M. E. King. 1986. Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. Clin. Chem. 32: 957-961.
28. Magkos, F., B. W. Patterson, B. S. Mohammed, S. Klein, and B. Mittendorfer. 2007. Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J. Clin. Endocrinol. Metab. In press.
29. Mittendorfer, B., O. Liem, B. W. Patterson, J. M. Miles, and S. Klein. 2003. What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes. 52: 1641-1648.
30. Zech, L. A., S. M. Grundy, D. Steinberg, and M. Berman. 1979. Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects. J. Clin. Invest. 63: 1262-1273.
31. Boer, P. 1984. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am. J. Physiol. 247: F632-F636.
32. Lewis, G. F. 1997. Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 8: 146-153.
33. Law, S. W., S. M. Grant, K. Higuchi, A. Hospattankar, K. Lackner, N. Lee, and H. B. Brewer, Jr. 1986. Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence. Proc. Natl. Acad. Sci. USA. 83: 8142-8146.
34. Hopkins, W. G. 2000. Measures of reliability in sports medicine and science. Sports Med. 30: 1-15.
35. Smith, S. J., G. R. Cooper, G. L. Myers, and E. J. Sampson. 1993. Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin. Chem. 39: 1012-1022.
36. Schectman, G., and E. Sasse. 1993. Variability of lipid measurements: relevance for the clinician. Clin. Chem. 39: 1495-1503.
37. Brenner, H., and G. Heiss. 1990. The intraindividual variability of fasting triglyceride - a challenge for further standardization. Eur. Heart J. 11: 1054-1058.
38. Jacobs, D. R., Jr., and E. Barrett-Connor. 1982. Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study. Am. J. Epidemiol. 116: 878-885.
39. Wasenius, A., M. Stugaard, J. E. Otterstad, and D. Froyshov. 1990. Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand. J. Clin. Lab. Invest. 50: 635-642.
40. Kafonek, S. D., C. A. Derby, and P. S. Bachorik. 1992. Biological variability of lipoproteins and apolipoproteins in patients referred to a lipid clinic. Clin. Chem. 38: 864-872.
41. Marcovina, S. M., V. P. Gaur, and J. J. Albers. 1994. Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. Clin. Chem. 40: 574-578.
42. Mjos, O. D., S. N. Rao, L. Bjoru, T. Henden, D. S. Thelle, O. H. Forde, and N. E. Miller. 1979. A longitudinal study of the biological variability of plasma lipoproteins in healthy young adults. Atherosclerosis. 34: 75-81.
43. Murphy, M. H., A. M. Nevill, and A. E. Hardman. 2000. Different patterns of brisk walking are equally effective in decreasing postprandial lipaemia. Int. J. Obes. Relat. Metab. Disord. 24: 1303-1309.
44. Hardman, A. E., and H. E. Aldred. 1995. Walking during the postprandial period decreases alimentary lipaemia. J. Cardiovasc. Risk. 2: 71-78.
45. Gill, J. M., and A. E. Hardman. 2000. Postprandial lipemia: effects of exercise and restriction of energy intake compared. Am. J. Clin. Nutr. 71: 465-471.
46. Robertson, M. D., R. A. Henderson, G. E. Vist, and R. D. Rumsey. 2002. Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. Am. J. Clin. Nutr. 75: 505-510.
47. Koutsari, C., D. Malkova, and A. E. Hardman. 2000. Postprandial lipemia after short-term variation in dietary fat and carbohydrate. Metabolism. 49: 1150-1155.
48. Gill, J. M., D. Malkova, and A. E. Hardman. 2005. Reproducibility of an oral fat tolerance test is influenced by phase of menstrual cycle. Horm. Metab. Res. 37: 336-341.
49. Walsh, B. W., I. Schiff, B. Rosner, L. Greenberg, V. Ravnikar, and F. M. Sacks. 1991. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 325: 1196-1204.